| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/20/2009 | US20090209004 Human il-1 beta antagonists |
| 08/20/2009 | US20090207970 Methods and Devices for Quantitative Analysis of X-Ray Images |
| 08/20/2009 | DE102008009609A1 Substituierte 4-(Indol-3-yl)chinazoline und deren Verwendung und Herstellung Substituted 4- (indol-3-yl) quinazolines and their use and production |
| 08/20/2009 | CA2715379A1 Formulation and method for the prevention and treatment of skeletal manifestation of gaucher's disease |
| 08/20/2009 | CA2714494A1 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 08/20/2009 | CA2703866A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090583A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090308A1 Pharmaceutical composition for the treatment or prevention of osteoarticular diseases |
| 08/19/2009 | EP2090307A1 Pharmaceutical composition for the treatment or prevention of osteoarticular diseases |
| 08/19/2009 | EP2089403A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
| 08/19/2009 | EP2089393A1 Heterocyclic compounds as antiinflammatory agents |
| 08/19/2009 | EP2089047A2 Compositions and methods for cardiac tissue protection and regeneration |
| 08/19/2009 | EP2089012A2 Polymorphs of n²-(1,1'- biphenyl- 4-ylcarbonyl)-n¹-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha -glutamine |
| 08/19/2009 | EP2035019A4 Prevention and treatment of osteochondrosis in animals and humans |
| 08/19/2009 | EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
| 08/19/2009 | EP1569672B1 Use of a centella asiatica extract rich in madecassoside and in terminoloside |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1343509B1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP0906415B1 Regeneration and augmentation of bone using mesenchymal stem cells |
| 08/19/2009 | CN101511841A Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors |
| 08/19/2009 | CN101511838A A pyrrolopyrazin as SYK-kinase inhibitor |
| 08/19/2009 | CN101511827A Pyridin-4-yl derivatives as immunomodulating agents |
| 08/19/2009 | CN101511783A N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 08/19/2009 | CN101511375A Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 08/19/2009 | CN101508720A Triterpene extracts of achyranthes bidentata and uses in osteosporosis resistant medicament |
| 08/19/2009 | CN101508693A Xylogen like flavonoid compounds, method of preparing the same and pharmaceutical use |
| 08/19/2009 | CN101507806A Sticking plaster capable of treating rheumathritis, hyperosteogeny, neck, shoulder, lumbar disease ache |
| 08/19/2009 | CN101507802A Medicine for treating ankylosing spondylitis |
| 08/19/2009 | CN101507784A Traditional Chinese medicine capable of promoting fracture healing |
| 08/19/2009 | CN101507783A Medicinal wine capable of treating |
| 08/19/2009 | CN101507768A Qiwei dan capable of treating arthralgia due to wind cold dampness |
| 08/19/2009 | CN101507758A Traditional Chinese medicine combination |
| 08/19/2009 | CN101507750A Use of kuhseng total-flavone in preparing medicine |
| 08/19/2009 | CN101507739A Biological agent containing human ARMET protein or oligonucleotide active constituent and use thereof |
| 08/19/2009 | CN101507736A Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism |
| 08/19/2009 | CN101507734A Deer-bone serial processing method |
| 08/19/2009 | CN101507711A Ligustrazine micro-spheres and preparation method thereof |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100529063C Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 08/19/2009 | CN100528846C Amine compounds and use thereof |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528242C Radioactive macroaggregate and its preparation method |
| 08/19/2009 | CN100528206C Jingangteng solution type solid dispersion, and application |
| 08/19/2009 | CN100528202C External application medicine on acupuncture point and its preparing method |
| 08/19/2009 | CN100528197C Chinese medicinal electuary for treating ankylosing spondylitis |
| 08/19/2009 | CN100528194C Medicine for treating femoral head necrosis |
| 08/19/2009 | CN100528183C Capsule for treating gout |
| 08/19/2009 | CN100528163C Oral cavity disintegration tablet for treating gout and its preparation method |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576050 Glucagon-like peptides and ependins for use in treatment and prevention of diabetes and neurodegenerative conditions; neuroprotective agents; neurotrophic factors |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |
| 08/18/2009 | US7575740 Applying to the tissue formulation comprising first precursor component second precursor component comprises electrophilic component which crosslink at physiological temperatures over a period of time following application |
| 08/18/2009 | CA2413736C Thorium or actinium radionuclides for endoradionuclide therapy |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/13/2009 | WO2009100107A2 Alendronate formulations, method of making and method of use thereof |
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009098144A1 Novel pyridinones and pyridazinones |
| 08/13/2009 | WO2009098127A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof |
| 08/13/2009 | WO2009097704A1 Antigen-binding polypeptides against cartilage degeneration |
| 08/13/2009 | WO2009008727A3 Molecules for targeting compounds to various selected organs or tissues |
| 08/13/2009 | WO2008064132A3 Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 08/13/2009 | US20090203739 Anti-Inflammatory Agents |
| 08/13/2009 | US20090203732 Thiazolones for Use as P13 Kinase Inhibitors |
| 08/13/2009 | US20090203714 Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203701 Prophylactic and/or therapeutic agent for rheumatoid arthritis |
| 08/13/2009 | US20090203668 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/13/2009 | US20090203650 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 08/13/2009 | US20090203648 Modified phosphocalcic compound, injectable composition containing same |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203632 Compositions and methods for treating contracture |
| 08/13/2009 | US20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090202660 Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation |
| 08/13/2009 | US20090202645 Intrasynovial formulations of stanozolol |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202572 Compositions and methods for modulating bone mass |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | CA2712965A1 Antigen-binding polypeptides against cartilage degeneration |
| 08/13/2009 | CA2711413A1 Alendronate formulations, method of making and method of use thereof |
| 08/13/2009 | CA2711399A1 3-substituted sulfonylpiperidine derivative |
| 08/13/2009 | CA2710462A1 Novel pyridinones and pyridazinones |
| 08/12/2009 | EP2088157A1 Collagen peptide composition and food or beverage containing the same |